Annual Non Current Assets
$10.43 M
+$3.69 M+54.64%
December 31, 2023
Summary
- As of February 7, 2025, OLMA annual long term assets is $10.43 million, with the most recent change of +$3.69 million (+54.64%) on December 31, 2023.
- During the last 3 years, OLMA annual non current assets has risen by +$9.85 million (+1683.25%).
- OLMA annual non current assets is now at all-time high.
Performance
OLMA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$12.18 M
-$191.00 K-1.54%
September 30, 2024
Summary
- As of February 7, 2025, OLMA quarterly long term assets is $12.18 million, with the most recent change of -$191.00 thousand (-1.54%) on September 30, 2024.
- Over the past year, OLMA quarterly non current assets has increased by +$1.39 million (+12.86%).
- OLMA quarterly non current assets is now -1.54% below its all-time high of $12.37 million, reached on June 30, 2024.
Performance
OLMA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
OLMA Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.6% | +12.9% |
| 3 y3 years | +1683.3% | +12.9% |
| 5 y5 years | +10000.0% | +12.9% |
OLMA Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.3% | -1.5% | +131.5% |
| 5 y | 5-year | at high | >+9999.0% | -1.5% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -1.5% | >+9999.0% |
Olema Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.18 M(-1.5%) |
| Jun 2024 | - | $12.37 M(+6.6%) |
| Mar 2024 | - | $11.60 M(+11.2%) |
| Dec 2023 | $266.51 M(+27.6%) | $10.43 M(-3.3%) |
| Sep 2023 | - | $10.79 M(+76.5%) |
| Jun 2023 | - | $6.12 M(-4.0%) |
| Mar 2023 | - | $6.37 M(-5.6%) |
| Dec 2022 | $208.90 M | $6.75 M(-2.8%) |
| Sep 2022 | - | $6.94 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $7.57 M(+5.1%) |
| Mar 2022 | - | $7.20 M(+37.0%) |
| Dec 2021 | $290.69 M(-15.0%) | $5.26 M(+247.2%) |
| Sep 2021 | - | $1.51 M(+10.1%) |
| Jun 2021 | - | $1.38 M(+32.8%) |
| Mar 2021 | - | $1.04 M(+77.1%) |
| Dec 2020 | $342.14 M(>+9900.0%) | $585.00 K(-63.3%) |
| Sep 2020 | - | $1.60 M(+5403.4%) |
| Dec 2019 | $103.00 K(-96.8%) | $29.00 K |
| Dec 2018 | $3.24 M | - |
FAQ
- What is Olema Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals annual non current assets year-on-year change?
- What is Olema Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly non current assets year-on-year change?
What is Olema Pharmaceuticals annual long term assets?
The current annual non current assets of OLMA is $10.43 M
What is the all time high annual non current assets for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual long term assets is $10.43 M
What is Olema Pharmaceuticals annual non current assets year-on-year change?
Over the past year, OLMA annual long term assets has changed by +$3.69 M (+54.64%)
What is Olema Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of OLMA is $12.18 M
What is the all time high quarterly non current assets for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly long term assets is $12.37 M
What is Olema Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, OLMA quarterly long term assets has changed by +$1.39 M (+12.86%)